anti cancer medicine

Generic Name: Eltrombopag Olamine Brand Name: TROMBONAMO Strength: 25 mg Dosage Form: Tablets Therapeutic Category: Hematology / Thrombopoietin Receptor Agonist Primary Use: Treatment of certain forms of thrombocytopenia Active Ingredient: Eltrombopag Olamine Product Overview TROMBONAMO 25 mg contains Eltrombopag Olamine, an oral thrombopoietin receptor agonist that stimulates the thrombopoietin receptor and promotes the proliferation and differentiation of megakaryocytes, thereby increasing platelet production. Eltrombopag products are used under medical supervision for conditions associated with low platelet counts, including persistent or chronic immune thrombocytopenia (ITP) and certain cases of severe aplastic anemia. Uses & Indications Eltrombopag may be prescribed for: Persistent or chronic immune thrombocytopenia (ITP) in patients who have not responded adequately to corticosteroids, immunoglobulins, or splenectomy. Severe aplastic anemia, including selected patients receiving standard immunosuppressive therapy. Certain cases of chronic hepatitis C-associated thrombocytopenia, according to applicable treatment protocols. How It Works Eltrombopag acts as a TPO-receptor agonist. It activates signaling through the thrombopoietin receptor, supporting megakaryocyte development and increasing platelet production. Benefits Oral tablet formulation Contains Eltrombopag Olamine Supports platelet production Used in specialized hematological treatment Available in a 25 mg strength Dosage & Administration The appropriate dose of eltrombopag varies according to the patient's condition, age, platelet response, liver status, and other clinical factors. TROMBONAMO 25 mg should be taken only according to the prescription and instructions of a qualified healthcare professional. Eltrombopag dosing is adjusted according to platelet response rather than being used simply to normalize platelet counts. Important Safety Information Eltrombopag requires appropriate medical monitoring. It may cause serious liver-related adverse effects, and hepatic function monitoring is recommended. Patients should inform their healthcare professional about existing liver conditions, other medicines, pregnancy or breastfeeding, and any history of blood-clotting problems before treatment. Possible adverse effects vary by patient and indication. Seek medical attention for unusual bleeding, symptoms suggestive of a blood clot, significant liver-related symptoms, or other serious reactions. Storage Store according to the manufacturer's labelled storage conditions. Keep the medicine in its original packaging, protected from unsuitable temperature, moisture, and direct exposure, and keep out of reach of children. Product Category Category: Hematology Subcategory: Thrombocytopenia / Platelet Disorder Medicines Drug Class: Thrombopoietin Receptor Agonist Why Choose MEDINDIA EXPORT? MEDINDIA EXPORT supports international pharmaceutical sourcing and medicine export requirements. We can assist buyers with product availability, quotation requests, documentation, and international shipping arrangements, subject to destination-country regulations. 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 Frequently Asked Questions 1. What is TROMBONAMO 25 mg? TROMBONAMO 25 mg contains Eltrombopag Olamine, a thrombopoietin receptor agonist used for certain conditions associated with low platelet counts. 2. What category does Eltrombopag belong to? It belongs to the hematology category and is classified pharmacologically as a thrombopoietin receptor agonist. 3. Is Eltrombopag used for low platelets? Yes. Eltrombopag is used for specific causes of thrombocytopenia, including persistent or chronic ITP. 4. Is TROMBONAMO 25 mg a prescription medicine? Eltrombopag should be used under the supervision and prescription of an appropriately qualified healthcare professional. 5. Can Eltrombopag be used for aplastic anemia? Eltrombopag has approved uses in certain patients with severe aplastic anemia, depending on the treatment setting and applicable regulatory guidance. 6. Can MEDINDIA EXPORT supply Eltrombopag 25 mg internationally? Availability, export documentation, and shipment depend on the destination country and applicable pharmaceutical regulations. Contact MEDINDIA EXPORT for current product and export information. Disclaimer: This catalogue information is for general product and pharmaceutical sourcing information only and does not replace professional medical advice, prescribing information, or local regulatory requirements. Availability and approved indications can vary by country. Mofilet-500 (Mycophenolate Mofetil Tablets USP 500 mg) catalogue page with contact details Mofilet-500 – Mycophenolate Mofetil Tablets USP 500 mg

Product Name: Erlonat 150 Active Ingredient: Erlotinib Strength: 150 mg Dosage Form: Film-Coated Tablet Pack Size: 30 Tablets Manufacturer: Natco Pharma Limited Product Category: Oncology / Anticancer Medicine Therapeutic Class: Antineoplastic / EGFR Tyrosine Kinase Inhibitor Product Overview Erlonat 150 contains Erlotinib 150 mg, an oral oncology medicine used in the management of certain cancers. Erlotinib belongs to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor class and works by inhibiting EGFR signalling involved in the growth and multiplication of certain cancer cells. Erlonat is available as a 150 mg tablet and is manufactured by Natco Pharma Limited. Natco's oncology portfolio lists Erlonat in 100 mg and 150 mg strengths with a 30-tablet retail pack. Uses Erlotinib may be prescribed by an oncologist for specific types of: Non-small cell lung cancer (NSCLC) Other cancers where erlotinib is clinically indicated The exact indication, dosage and duration depend on the patient's cancer type, clinical condition and treatment plan. Key Product Features Erlotinib 150 mg per tablet Oral tablet formulation Oncology / anticancer medicine Manufactured by Natco Pharma Limited 30-tablet pack Prescription medicine How It Works Erlotinib blocks the activity of EGFR, a protein involved in signalling that can promote cancer-cell growth. By inhibiting this pathway, erlotinib can help slow the growth of certain EGFR-dependent cancer cells. Important Safety Information Erlotinib is a prescription oncology medicine and should be used only under the supervision of a qualified healthcare professional. The prescribing doctor should determine whether the medicine is appropriate based on the patient's diagnosis and other medicines being taken. Possible adverse effects can include skin rash, diarrhoea, loss of appetite, nausea, fatigue and other reactions. Patients should seek medical attention for severe or unusual symptoms. Storage Store according to the manufacturer's labelled storage instructions and keep the medicine away from excessive heat and moisture. Keep out of reach of children. Export & Wholesale Enquiries We support enquiries for pharmaceutical products from international buyers, subject to applicable pharmaceutical regulations, import requirements, product registration and patent laws in the destination country. Website: www.medicineindiaexport.com Email: sales.medindiaexport@gmail.com WhatsApp: +91 7218129896

Product Name: Erlonat 100 Generic Name: Erlotinib Strength: 100 mg Dosage Form: Tablet Pack Size: 30 Tablets Manufacturer: Natco Pharma Therapeutic Category: Oncology / Anticancer Medicine Country of Origin: India Product Description Erlonat 100 contains Erlotinib 100 mg, an EGFR tyrosine kinase inhibitor used for specific cancer indications under specialist medical supervision. It is a prescription oncology medicine and should be used only as directed by a qualified healthcare professional. Key Product Information Composition: Erlotinib 100 mg Form: Oral tablet Brand: Erlonat 100 Manufacturer: Natco Pharma Pack: 30 tablets Category: Anticancer / Oncology Supply: Subject to availability and applicable export regulations International Export Markets We accept pharmaceutical trade inquiries from buyers across USA, Canada, UK, Germany, France, Italy, Spain, Netherlands, Australia, New Zealand, UAE, Saudi Arabia, Qatar, Kuwait, Singapore, Malaysia, Thailand, Brazil, Mexico, Argentina, South Africa, Nigeria, Kenya, Ghana, Egypt, Morocco, Turkey, Japan, South Korea, Indonesia, Philippines, Vietnam, Bangladesh, Nepal, Sri Lanka and other permitted international markets. Export & Trading FAQs Q: Do you export Erlonat 100 mg? Yes, international sourcing inquiries can be discussed subject to product availability and applicable regulations. Q: Is Erlonat 100 a prescription medicine? Yes. Erlotinib is a prescription oncology medicine. Q: Do you offer bulk supply? Bulk and wholesale requirements can be discussed based on quantity, availability, destination, and regulatory requirements. Q: What information is needed for a quotation? Please provide the required quantity, destination country, and buyer/company details. Contact MEDINDIA EXPORT 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896